Specification for ventilators to be used in UK hospitals during the coronavirus (COVID-19) outbreak

AI Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) issued guidance regarding the supply and regulation of ventilators designed to treat Acute Respiratory Distress Syndrome (ARDS) resulting from SARS-CoV-2. The document clarifies that the United Kingdom’s immediate clinical requirement for these devices has been met through a combination of existing market-certified ventilators and successful entries from the Ventilator Challenge initiative. Consequently, the MHRA and the Cabinet Office are no longer accepting new applications for ventilator designs under this specific emergency program. The regulatory framework governing these devices included specific exemptions from standard medical device regulations enacted during the COVID-19 pandemic to expedite availability. Additionally, the MHRA provided detailed specifications for Rapidly Manufactured CPAP Systems to ensure safety and efficacy during the health crisis. While the UK is not seeking new domestic submissions, the MHRA acknowledges that international organizations, such as the World Health Organization (WHO), continue to reference these UK specifications for their own emergency response efforts. Manufacturers and interested parties are directed to the Cabinet Office for further information regarding the Ventilator Challenge and are encouraged to access British Standards Institution (BSI) documentation, which has been made available free of charge. No specific company violations or inspection dates were noted, as the document serves as a status update on national supply and regulatory procedures rather than an enforcement action.